M.E. Allison & Co
GILD icon

M.E. Allison & Co’s Gilead Sciences GILD Stock Holding History

M.E. Allison & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$541K Hold
3,633
– – 0.3% 89
2026
Q2 		$459K Hold
3,633
– – 0.26% 100
2026
Q1 		$506K Hold
3,633
– – 0.34% 80
2025
Q4 		$446K Hold
3,633
– – 0.3% 88
2025
Q3 		$403K Hold
3,633
– – 0.28% 90
2025
Q2 		$403K Hold
3,633
– – 0.32% 82
2025
Q1 		$407K Hold
3,633
– – 0.4% 75
2024
Q4 		$336K Buy
+3,633
New +$327K 0.37% 82

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

M.E. Allison & Co's GILD Position: Q3 2026 in Review

M.E. Allison & Co held its Gilead Sciences (GILD) position steady in Q3 2026 at 3,633 shares worth $541K. The position accounts for 0.3% of the portfolio, ranked #89.

M.E. Allison & Co first reported a position in GILD in Q4 2024 and has held it in 8 quarters since. 488 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • M.E. Allison & Co held 3,633 shares of Gilead Sciences worth $541K as of Q3 2026.
  • M.E. Allison & Co left its Gilead Sciences share count unchanged in Q3 2026.
  • Gilead Sciences made up 0.3% of M.E. Allison & Co's portfolio in Q3 2026, its #89 holding.
  • M.E. Allison & Co first reported a position in Gilead Sciences in Q4 2024 and has held it in 8 quarters since.
  • 488 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on M.E. Allison & Co's 13F filing for Q3 2026, filed 9 Oct 2026.